NEWARK, DE / ACCESSWIRE / November 24, 2022 / A recently published study by FMI expects the global high potency API contract manufacturing market to augment at a 7% CAGR from 2022 to 2032. By the ...

Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Biologic API Contract Manufacturer Quality Benchmarking (6th Edition)" report has been added to ResearchAndMarkets.com's offering. This Biologic API ...

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...